Hanyu Pharmaceutical: Terliparatide (H) Injection Obtains Drug Registration Certificate
2026-11-13 17:01:04
According to CoinMeta, Hanyu Pharmaceutical announced that its drug teriparatide (H) injection has obtained a drug registration certificate. Teriparatide is a recombinant human parathyroid hormone (1-34) analog, suitable for the treatment of osteoporosis in postmenopausal women at high risk of fractures.
Bullish 0
Bearish 0
Source:Jin10 Data
This content is for market information only and does not constitute investment advice.